Science and Research

Cardiomyocyte loss is not required for the progression of left ventricular hypertrophy induced by pressure overload in female mice

Left ventricular (LV) hypertrophy in response to hypertension and increased afterload frequently progresses to heart failure. It is under debate whether the loss of cardiomyocytes contributes to this transition. To address this question, female C57BL/6 wild-type mice were subjected to transverse aortic constriction (TAC) and developed compensated LV hypertrophy after 1 week, which progressed to heart failure characterized by reduced ejection fraction and pulmonary congestion 4 weeks post-TAC. Quantitative, design-based stereology methods were used to estimate number and mean volume of LV cardiomyocytes. DNA strand breaks were visualized using the TUNEL method 6 weeks post-TAC to quantify the number of apoptotic cell nuclei. The volume of the LV myocardium as well as the cardiomyocyte mean volume increased progressively after TAC. In contrast, the number of LV cardiomyocytes remained constant 1 and 4 weeks post-TAC in comparison to sham-operated mice. Moreover, there was no significant difference in the number of cardiomyocyte nuclei stained for DNA strand breaks at 6 weeks post-TAC. It was concluded that the loss of cardiomyocytes is not required for the transition from compensated hypertrophy to heart failure induced by TAC in the female murine heart.

  • Schipke, J.; Grimm, C.; Arnstein, G.; Kockskamper, J.; Sedej, S.; Muhlfeld, C.

Keywords

  • Animals
  • Apoptosis
  • Cell Count
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Hypertrophy, Left Ventricular/*pathology
  • Mice, Inbred C57BL
  • Myocytes, Cardiac/*pathology
  • Pressure
  • cardiomyocyte number
  • design-based stereology
  • hypertrophy
  • transverse aortic constriction
Publication details
DOI: 10.1111/joa.12463
Journal: Journal of anatomy
Pages: 75-81 
Number: 1
Work Type: Original
Location: BREATH
Disease Area: PH
Partner / Member: MHH
Access-Number: 26990078
See publication on PubMed

DZL Engagements

chevron-down